Search

everythinglearnresearchcommunity

for

Search:↓

Low testosterone and 5α-reductase inhibitors can harm men's metabolic and sexual health; testosterone therapy may help, but discussing 5α-RIs' side effects is important.

Medications for BPH can have significant side effects, so understanding these risks is important for treatment decisions.

Ganoderma lucidum may help treat prostate cancer by blocking male hormones and slowing cancer cell growth.

Hormone therapy for prostate cancer can increase heart risks, especially in men with heart conditions.

TMPRSS2 helps viruses enter cells and protects the prostate from inflammation-related cancer.

DHT is a strong androgen that may pose less risk to the prostate compared to testosterone.

Some hair loss and prostate drugs might increase the risk of diabetes and heart disease.

Liquorice may reduce testosterone and affect male reproductive organs, potentially helping treat conditions like prostate cancer.

Smaller substituents at C-17 enhance the inhibitory activity of progesterone derivatives on 5alpha-reductase.

No definitive link between finasteride and male breast cancer, but further research is needed.

New treatments for prostate cancer and BPH show promise, including novel compounds that target hormone synthesis and response.

Drinking a lot of alcohol increases the risk of prostate cancer and can worsen the condition.

Dosing time affects finasteride's effectiveness and safety in rats.

Kigelia africana fruit extract can prevent and reverse prostate enlargement in rats.

Finasteride may cause breast enlargement, low testosterone a risk factor.

The developed model can predict effective 5-alpha-reductase enzyme inhibitors.

Plant-based compounds might be effective, low-side-effect treatments for prostate cancer by blocking a specific enzyme.

Plant-based treatments may help reduce BPH symptoms, but more research is needed.

CT scans can find serious prostate cancer even when PSA levels are low.

The models can help find better inhibitors for conditions like baldness and prostate disorders.

A castrated dog developed hair loss and prostate issues from long-term exposure to estrogen cream.

The workshop highlighted the genetic links and psychological impacts of hair loss and skin disorders.

Finasteride reduces prostate size and PSA levels in young men with hair loss.

Riboflavin 5′-phosphate (FMN) shows potential for treating androgen-related conditions but may be limited in treating prostate cancer.

There is no clear recommendation for using selenium in cancer patients; it may be beneficial to correct low selenium levels before treatment.

Prostasin has two roles in skin: one for normal skin development without needing activation, and another for proper hair growth that requires activation.

The document explains how to do skin procedures, care after surgery, and when to use certain treatments.

Scientists created iodinated arylhydantoins and arylthiohydantoins that could potentially be used for imaging prostate cancer. Some versions with specific side-chains showed high potential for this use.

Androstenedione, a hormone supplement, doesn't improve muscle or performance and can cause harmful side effects.

Finasteride reduces hair loss and treats BPH without major hormone changes, but may cause sexual dysfunction.